Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

NCT04365725 · clinicaltrials.gov ↗

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Remdesivir

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

URC-CIC Paris Descartes Necker Cochin